Aurora Spine Corp. engages in the development and distribution of spinal implant products. The company is headquartered in Toronto, Ontario. The company went IPO on 2013-09-10. The Company’s products generally fall into three product lines: interspinous process (ISP) lumbar fusion devices, Stand-alone (SA) Cervical and Lumbar fusion cages, and SI joint fusion devices. Its ISP lumbar fusion devices include the ZIP, the ZIP ULTR, the ZIP LP and the ZIP-51. The company also offers a line of interbody products: Discovery for cervical procedures; SOLO, an ALIF 3D-printed stand-alone lumbar fusion device; SiLO, a posterior allograft implant; and SiLO TFX, a titanium implant device, both for sacroiliac (SI) joint fusion, and Dexa-C a 3D printed cervical fusion device which is paired with the Apollo cervical plate. In addition, the Company markets certain third-party-developed products used during spine surgeries (i.e. surgical screws and bone growth biologic materials).
Follow-Up Questions
Aurora Spine Corp의 CEO는 누구입니까?
Mr. Trent Northcutt은 2012부터 회사에 합류한 Aurora Spine Corp의 President입니다.
ASAPF 주식의 가격 성능은 어떻습니까?
ASAPF의 현재 가격은 $0.2이며, 전 거래일에 decreased 0% 하였습니다.
Aurora Spine Corp의 주요 사업 주제나 업종은 무엇입니까?
Aurora Spine Corp은 Health Care 업종에 속하며, 해당 부문은 Health Care입니다